ACTIVITY NUMBER:  MHPTM002

ACTIVITY TITLE:  Mental Health Professional Training Modules Part 2:  Treatment Interventions

CREDIT DESIGNATION STATEMENT

The American Society for Reproductive Medicine designates this enduring material for a maximum of 7.00 AMA PRA Category 1 Credits^TM.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

ACCREDITATION STATEMENTS

The American Society for Reproductive Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Mental Health Professionals Group of the American Society for Reproductive Medicine is approved by the American Psychological Association to sponsor continuing education for psychologists.  This activity will offer 7.00 continuing education credits.  The Mental Health Professionals Group of the American Society for Reproductive Medicine maintains responsibility for this program and its content.

Release Date:  June 1, 2017

Reviewed/Updated:  2020

Reviewed/Updated:  January 5, 2023

Expiration Date:  January 5, 2026

Estimated Time to Complete Activity:  7.00 hours

NEEDS ASSESSMENT and IDENTIFICATION OF PRACTICE GAP

Mental Health Professionals experience significant challenges when working in reproductive medicine. The competence required to practice in this area does not carry over from other mental health care settings.  Treatment interventions that take into consideration the scientific, medical, and psychological aspects of infertility treatments must be designed and/or adapted specifically for infertility patients.  As new treatments evolve, complex ethical and legal/regulatory issues arise. Psychological research must be rigorous and suitably designed to address the unique questions in this field.  Part 2 of the Mental Health Professional Training Modules provides an opportunity for mental health practitioners to be introduced to and understand treatment interventions, ethics, fertility preservation and research in assisted reproductive technology. Successful completion of Part 1, Mental Health Professional Training Modules: Basic Infertility is a prerequisite to this course.

DISCLAIMER

Completion of the MHPG Training Modules or any of their components does not provide credentials to practice as a mental health professional in the assisted reproductive technology setting.

EDUCATIONAL OBJECTIVES

At the conclusion of the educational activity, participants should be able to:

1.      Analyze and apply ethical principles in treating patients using assisted reproductive technologies (ART).

2.      Identify treatment interventions that are relevant for patients in ART.

3.      Apply the basic principles of research applicable to ART psychological paradigms.

COURSE OUTLINE

Lesson 1              Ethical Practices in Fertility Counseling

                                                1A          Ethical Principles

1B          Ethical Dilemmas

1C          Implicit Bias

Lesson 2              Cognitive and Dialectical Behavior Informed Therapy for Infertility

Lesson 3              Couples Counseling in Infertility:  Emotionally Focused Therapy (EFT)

Lesson 4              The Intersection of Sexual Function and Infertility

Lesson 5              Infertility and Grief Counseling

Lesson 6              Stress Management and Coping:  Approaches to Working with the Infertility Patient

Lesson 7              Psychotropic Medications for Depression and Anxiety during Assisted Reproductive Technology (ART) and Pregnancy

Lesson 8              Clinical Research:  Fertility and Reproductive Medicine

Lesson 9              The Role of Mental Health Professionals in Adult Fertility Preservation

TARGET AUDIENCE

This activity has been designed to meet the educational needs of mental health professionals involved in infertility care.

ACGME COMPETENCY

Medical Knowledge

Patient Care

Interpersonal and Communication Skills

Professionalism

SUCCESSFUL COMPLETION REQUIREMENTS

Successful completion of this activity requires the learner to:

·        Successfully complete MHPCC001/MHPTM Part 1:  Basic Infertility as a prerequisite for this training module

·        View a course overview page, containing all CME and disclosure information, including acknowledgement of commercial support and disclosure of unlabeled use, prior to the start of each module.

·        Complete a 45-question pre-exam prior to the training module.  Learners should note any pre-exam questions answered incorrectly for clarification during module study.

·        Be given the option of downloading printed presentation and supporting materials.

·        Participate in the interactive activities:  audio narration is synchronized with presentation materials that can be advanced, stopped, or reversed as desired.

·        After completion of all 9 lessons, take a 45-question post-exam, with feedback of correct/incorrect answers, scoring a minimum of 75% in two attempts.

·        Complete the evaluation survey.

·        Print certificate of completion.

DISCLOSURES FOR PLANNERS AND FACULTY

Planners

Michelle Landrum, EdD(c) – Nothing to Disclose

Harriet Smith, M.Ed – Nothing to Disclose

Shelley Lee, PhD – Nothing to Disclose

Irena Milentijevic, PsyD – Nothing to Disclose

Melanie Mikkelsen - Nothing to Disclose

Ariadna Cymet-Lanski - Nothing to Disclose

Susan A. Gitlin, PhD – Nothing to Disclose

Content Developers and Reviewers

Kim Bergman, PhD – Nothing to Disclose

Angela Lawson, PhD – Nothing to Disclose

Danielle Kaplan, PhD – Nothing to Disclose

Irena Milentijevic, PsyD – Nothing to Disclose

Bill Petok, PhD – Nothing to Disclose

Melanie Mikkelsen, MSW, LICSW – Nothing to Disclose

Piave Lake, MD - Nothing to Disclose

Jessica Clifton, PhD - Nothing to Disclose

Jean Benward, MSW – Nothing to Disclose

Kris Bevilacqua, PhD – Nothing to Disclose

Julie Bindeman, PhD - Nothing to Disclose

Andrea Braverman, PhD – Nothing to Disclose

Shara Brofman, PhD – CVS Stock Ownership

Nicole Cirino, MD – Nothing to Disclose

Bonnie Cochran, LCSW – Nothing to Disclose

Alice Domar, PhD – Consultant:  Merck, Ferring, Ovascience; Ownership/Stock:  TriaDea Integrative Health Center and FertiCalm

Amanda Ellis, RN, BSN – Nothing to Disclose

Allison Fagan, PhD – Spouse on Speaker’s Bureau – AstraZeneca, Allergan, Mylan

Nancy Freeman-Carroll, PsyD – Nothing to Disclose

Joann Galst, PhD - Nothing to Disclose

Elizabeth Grill, PsyD – Co-Owner:  Ferticalm, AlizHealthcare

Judith Horowitz, PhD – Nothing to Disclose

Daniel Kaser, MD - Nothing to Disclose

Sheryl Kingsberg, PhD – Paid Consultant:  Valeant, Acerus, Emotional Brain, Pfizer, Shionogi, Sermonix, NovoNordisk, Perrigo, Nuelle, Materna, Palatin; Stock Options:  Viveve

Sue Clock, PhD – ForsMarsh, LLC

Lauri Pasch, PhD – Nothing to Disclose

Debra Reuben, PhD – Nothing to Disclose

Mindy Shiffman, PhD – Nothing to Disclose

Carly Snyder, MD – Speaker:  Sage Therapeutics

Irene Souter, MD – Nothing to Disclose

Margot Weinshel, LCSW, RN – Nothing to Disclose

Julianne E. Zweifel, PhD – Nothing to Disclose 

It is the policy of the ASRM to ensure balance, independence, objectivity, and scientific rigor in all its educational activities.  All faculty/authors participating in this activity are expected to disclose any relationships they may have with companies whose products or services may be mentioned so that participants may evaluate the objectivity of the presentations.  The content and views presented in this activity are those of the faculty/authors and do not necessarily reflect those of the ASRM.  Any discussion of off-label, experimental, or investigational use of drugs or devices will also be disclosed.  The disclosure statements were reviewed by the Subcommittee for Standards of Commercial Support of the CME committee of ASRM and any perceived conflicts of interest were resolved in accordance with the policies of the ACCME.

ACKNOWLEDGEMENT

This CME activity is sponsored by the American Society for Reproductive Medicine

STATEMENT of SUPPORT